Co-Authors
This is a "connection" page, showing publications co-authored by José Aguado and Joaquín Martínez-López.
Connection Strength
0.626
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study. Int J Infect Dis. 2021 Apr; 105:319-325.
Score: 0.232
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study. J Med Virol. 2021 02; 93(2):831-842.
Score: 0.224
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. Int J Infect Dis. 2021 Apr; 105:487-494.
Score: 0.058
-
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol. 2020 Nov; 105(5):597-607.
Score: 0.056
-
IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 10; 146(4):799-807.e9.
Score: 0.056